Additionally, although P value was bigger than 0.05, we still identified that high FHL2 expression was correlated with poor OS patients with stage I, stage III, stage IV, T1, T3, T4, N0, N1 and M1 NSCLC. The gene discussed is FHL2; the disease is non-small cell lung carcinoma.